Bayer's incoming CEO Anderson won't rule out consumer, agriculture spinoffs
Opioid wearable opens a large market opportunity for Masimo
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
A lean first quarter for venture-backed developers
*please scroll down for all the latest news*
